EATG » News

Webinar: Results of the METRODORA research on the involvement of women in HIV clinical trials

EATG will host a webinar on the Results of the METRODORA research on the involvement of women in HIV clinical trials on Wednesday, 02 May 2018, 13:00 – 14:00 CEST…

Webinar: Introduction to medicine research and development

EATG will host a webinar, Introduction to medicine research and development, on Thursday, 26 April 2018, 18:00 – 19:00 CEST (Brussels, Berlin, Paris time). The webinar will be led by…

Positive Stories: the voices of women living with HIV across Europe

The EATG has launched a new initiative aiming to give women living with or affected by HIV a platform to make their voices heard. Positive Stories is an empowerment tool…

Grindr sharing the HIV status and other personal information of their users with third parties without their informed consent is unacceptable

The EATG is disturbed by the news, reported by BuzzFeed News, about Grindr sharing the HIV status information of their users with two third companies, Apptimize and Localytics. Such actions…

PARADIGM: A collaborative initiative on patient engagement kicks-off

PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines), a new initiative regarding patient engagement in research and development of medicines, was launched this week during…

STEP-UP 2018/19: Call for participants

The European AIDS Treatment Group (EATG) is happy to launch the call for participants for the STEP-UP 2018/19 training programme today. The STEP-UP programme is designed for people living with…

Metrodora: Webinar on women’s participation in HIV research

EATG will host a webinar on women’s participation in HIV research on 4 April 2018, 17:00 – 18:00 CET (Brussels, Berlin, Paris time). The webinar is organized within the context…

Civil society and patient organisations are seeking EU leadership and action on HIV, Hepatitis and TB

The European AIDS Treatment Group, along with other civil society and patients organisations, has co-signed an open letter to Commissioner Andriukaitis in view of the upcoming Staff Working Document on…

Organisations are urging Commissioner Andriukaitis to foster EU Member States’ response to Tuberculosis

In view of upcoming World Tuberculosis (TB) Day on March 24, the TB Europe Coalition, supported by 34 civil society and community organisations, urge Commissioner Andriukaitis to make a public…

Call for WHO & UNODC to revise guidelines on International Standards for the Treatment of Drug Use Disorders

The European AIDS Treatment Group together with 188 organisations has co-signed an open letter initiative by the International Network of People who use Drugs addressed to the WHO and UNODC…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

Webinar: Patient-reported Outcomes (PROs)

We invite you to join the webinar on What are patient-reported outcome measures and how are they used in drug development? taking place on Tuesday, 27 March 2018, 18:00 –…

THE EU CIVIL SOCIETY FORUM ON HIV, TB AND VIRAL HEPATITIS URGES THE EUROPEAN COMMISSION TO PRIORITIZE PUBLIC HEALTH WITHIN THE UPCOMING FINANCIAL FRAMEWORK

On 6 March the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the European Commission President Juncker, as well as Budget and Health Commissioners, in response to the…

Metrodora: Call for applications in the Multi-Stakeholders’ Meeting

Call for applications: Multi-Stakeholders’ Meeting Meaningful Engagement of Women in HIV Treatment Research Wednesday 16 May 2018, Park Inn Hotel, Brussels, Belgium   The Meeting: Within the framework of the…

The EU Civil Society Forum on HIV, TB and Viral Hepatitis calls the Romanian Ministry of Health to take on a leadership role on EU viral hepatitis policies

On 26 February, the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the Romanian Ministry of Health to request that it uses its convening power and…

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention,…

Community reception at CROI 2018

You are invited to the annual Community reception at CROI on 6 March 2018! For full details, please download the invitation for the event here: Community reception at CROI 2018,…

Presentations from the PrEP Summit now online

Organised jointly by EATG, AVAC, AIDSfonds, AIDES, AIDS Action Europe, NAM-AIDSMAP, NAT, Prepster, UNAIDS, WHO, the European PrEP Summit was organised in Amsterdam on 9-10 February 2018. The more than…

Advancing Community Agency - EATG Stakeholder Meeting in Brussels

The European AIDS Treatment Group held its annual Stakeholder Meeting in Brussels on 22 January 2018. The event welcomed 21 guests - partners and funders of EATG - who met…

M-Care 2018: Call for participants

The European AIDS Treatment Group (EATG) and the Africa Advocacy Foundation (AAF) are announcing a call for participants for the M-Care 2018 training programme. The goal of the training is…

Half of Europe’s clinical trials fail to report results despite EU rule

LONDON, September 13, 2018 - Almost half of all European-registered clinical trials - in which scientists test drug treatments, interventions or therapies in humans - have breached EU rules by failing…

Largest study of ‘post-treatment controllers’ reveals clues about HIV remission

Some HIV patients maintain low viral loads after stopping treatment; early treatment and HIV reservoir size may be the keys Most HIV patients need to take daily anti-retroviral therapy -…

Portugal approves sale of test kits for HIV, hepatitis in pharmacies

Lisbon, Sept. 13 -- Kits to test HIV, hepatitis B and C will be allowed to be sold in Portugal's pharmacies without prescription under new legislation approved by the government…

Psychological relief is the most important benefit of a hepatitis C cure for patients

When asked to describe what their hepatitis C cure meant to them, Australians who had recently completed treatment emphasised an improved sense of psychological wellbeing, according to a qualitative study…

High rates of smoking in people with HIV in sub-Saharan Africa

Having HIV is associated with a greater likelihood of cigarette smoking and using smokeless tobacco, according to research conducted in 25 sub-Saharan African countries and published in Nicotine and Tobacco…

Shhh … UN Declaration on TB draft text out for approval

Negotiators’ agreed draft text for a United Nations political declaration on ending tuberculosis worldwide has been posted for all member states to see, and negotiators hope, not comment on. Under…

Russian Federation commits to reach 75% antiretroviral therapy coverage in 2019

The Russian Minister of Health, Veronika Skvortsova, has reiterated the commitment to reach the targets agreed at the 2016 United Nations General Assembly High-Level Meeting on Ending AIDS. “We have…

Drug price cut will expand access to a key treatment for HIV coinfections

GENEVA, 12 September 2018 – Unitaid welcomes the announcement by Gilead Sciences, Inc. that it will cut the price of the WHO-recommended drug AmBisome® to treat cryptococcal meningitis, an opportunistic infection…

Gilead Sciences and Precision BioSciences announce collaboration to develop therapies against hepatitis B virus using ARCUS genome editing

FOSTER CITY, Calif. & DURHAM, N.C., Sep. 12, 2018-- Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the companies have entered into a strategic collaboration to develop therapies…

Northern Ireland: New HIV clinic to offer access to PrEP drug

A new HIV prevention clinic is to transform how HIV services are delivered to people in Northern Ireland. The regional HIV prevention clinic will be based in the Belfast Trust.…

US: Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

Immunotherapy shows promise for HIV-related Kaposi sarcoma

Six out of nine patients experienced cancer remission with Opdivo or Keytruda. Treatment with immune checkpoint inhibitors led to complete or partial tumor shrinkage in two thirds of HIV-positive people…

Aspirin regimen reduces HIV target cells, could cut HIV transmission risk

A daily regimen of low-dose aspirin might be a viable HIV-prevention tool in high-risk populations, particularly where other prevention measures are not widely available, according to a small 6-week study…

Views from the front lines: Supervised consumption services and overdose prevention sites

CATIE spoke to two service providers about the issues relating to the operation of supervised consumption services and overdose prevention sites in Canada. Lorraine Barnaby, Supervised Consumption Service Manager, Parkdale…

Special antibodies could lead to HIV vaccine

Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against…

Starting from here – what PrEP programmes can learn from circumcision

Funders, health providers and advocates should take lessons from the rollout of voluntary medical male circumcision (VMMC) as an HIV prevention measure in Africa if they wish to hasten access…

HIV does not increase risk of acute coronary syndrome recurrence

Although previous studies have shown that individuals infected with human immunodeficiency virus (HIV) are at increased risk for acute coronary syndrome (ACS), including myocardial infarction, a new large health care…

Groups call for end to Gilead’s unwarranted hepatitis C drug monopoly in Europe

Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment NEW YORK/MUNICH/PARIS, SEPTEMBER 11, 2018—This week in Munich, the European Patent Office (EPO) will hear a legal challenge…

HIV prevention pill reaching more people who need it

More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.…

Adding a chest X-ray to the WHO four-symptom screening rule may help detect TB in HIV patients

Adding a chest x-ray to the World Health Organization (WHO) four-symptom screening rule for tuberculosis (TB) may help detect more cases in people living with HIV while decreasing specificity, according…